AI-assisted, human-published
08/10/2026 /Funding Events
Expedition Therapeutics Raises $115 Million in Series B Funding for Drug Development
Expedition Therapeutics closes an oversubscribed $115 million Series B financing, led by General Atlantic, to advance oral small molecule therapies for inflammatory and respiratory diseases.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com
